Loading...
Loading...
According to a research report published this morning, Bank of America has downgraded KEMET
KEM from Buy to Underperform, and lowered PO from $12 to $8.
In the report, Bank of America commented, "We are downgrading shares of Kemet to Underperform from Buy given our view that the road to improvement in earnings will be a long one. We view primary headwinds as (1) slow recovery in Film and Electrolytic (F&E) margins from an unexpected breakeven gross margin in the latest reported quarter, (2) execution risk associated with multiple significant undertakings (restructuring, integration of Niotan, pending stake in NEC-Tokin), (3) increased interest expense from recently issued debt to fund the M&A, and (4) an uncertain macroeconomic environment."
KEMET closed yesterday at $7.52.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in